Sir-We thank you for your interest in our paper concerning treatment of prosthetic joint infections (PJI) caused by Propionibacterium acnes (Jacobs et al. 2015) . You made an interesting comment about one of your papers we cited to support our statement "the successful eradication of Propionibacterium biofilms with rifampicin in in-vitro studies". Few studies have shown a possible benefit of rifampicin in the treatment of P. acnes PJI, despite the established effectiveness in staphylococcal PJI. We interpreted your paper (Bayston et al. 2007 ) and the paper of Furustrand Tafin et al. (2012) that there is in vitro evidence suggesting an effect of rifampicin on P. acnes biofilms. The equal effect on the eradication of P. acnes biofilms in vitro by penicillin alone and linezolid plus rifampicin is interesting. Unfortunately, despite the in vitro susceptibility of P. acnes to penicillin the long-term clinical use of penicillin to treat a PJI caused by P. acnes has some difficulties including the treatment duration of a PJI of 3 months and the necessity to use the drug intravenously to achieve adequate levels at the site of infection. Therefore, we prefer to use clindamycin in the treatment of PJI caused by P. acnes, which is also recommended in the IDSA guidelines as an alternative treatment option (Osmon et al. 2012 ). Department of Orthopedic Surgery, Prosthetic Joint Infection Unit, Sint Maartenskliniek Nijmegen, the Netherlands E-mail: anouk.jacobs@hotmail.com 
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